Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1022 studies found for:    Attention Deficit-Hyperactivity Disorder
Show Display Options
Rank Status Study
1 Completed An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: methylphenidate hydrochloride
2 Completed
Has Results
Adult Attention Deficit Hyperactivity Disorder
Condition: Adult Attention Deficit Hyperactivity Disorder
Interventions: Drug: SEP-225289;   Drug: Placebo
3 Completed
Has Results
An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
Condition: Attention-Deficit Hyperactivity Disorder
Interventions: Drug: JNS001;   Drug: Placebo
4 Completed
Has Results
Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: CLONICEL (Clonidine HCl sustained release)
5 Completed
Has Results
Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: clonidine hydrochloride;   Drug: Placebo
6 Completed
Has Results
A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: PF-03654746;   Drug: Placebo capsules
7 Completed A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: methylphenidate hydrochloride extended-release tablets
8 Recruiting A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Condition: Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: dasotraline 4mg;   Other: Placebo
9 Completed Cognitive-Behavioural Therapy (CBT) for Adult Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Other: CBT plus treatment as usual;   Other: Treatment as usual
10 Withdrawn Effect of Methylphenidate on Connectivity
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Methylphenidate;   Other: Placebo
11 Terminated
Has Results
Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE
Conditions: Attention Deficit Hyperactivity Disorder;   Cannabis Abuse
Intervention: Drug: Atomoxetine
12 Completed Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Other: Behavioral assessment and NAT EEG tests
13 Unknown  Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention:
14 Recruiting The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate
15 Completed Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: OROS MPH;   Drug: Atomoxetine
16 Completed
Has Results
A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: Osmotic Release Oral System Methylphenidate Hydrochloride (OROS-MPH);   Other: No intervention
17 Completed Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: NRP104
18 Enrolling by invitation Intensive Executive Function Training
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Behavioral: intensive Executive function training
19 Completed
Has Results
Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Long-Acting Methylphenidate
20 Completed
Has Results
Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder
Conditions: Attention Deficit Hyperactivity Disorder;   Substance Abuse
Interventions: Drug: Atomoxetine;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.